Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novartis AG ADR | 3 | 0 | 0 | 0 | €107.50 | €112.40 | 4.556% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.40 | €130.00 | 6.209% |
| Acadia Pharmaceuticals | 35 | 1 | 0 | 0 | €14.82 | €29.92 | 101.926% |
| CONMED Corp. | 15 | 2 | 1 | 0 | €65.50 | €98.42 | 50.256% |
| Repligen Corp. | 15 | 0 | 0 | 0 | €128.40 | €178.01 | 38.639% |
| Biocryst Pharmaceuticals | 7 | 0 | 0 | 0 | €7.47 | €11.13 | 49.068% |
| Henry Schein Inc. | 15 | 1 | 0 | 0 | €63.84 | €76.08 | 19.172% |
| Amicus Therapeutics Inc. | 8 | 0 | 0 | 0 | €10.40 | €17.63 | 69.566% |
| Jazz Pharmaceuticals plc | 30 | 0 | 0 | 0 | €99.00 | €183.41 | 85.267% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 2 | 0 | €20.75 | €54.98 | 164.969% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 0 | 0 | €41.64 | €95.00 | 128.146% |
| Fresenius SE & Co. KGaA | 3 | 1 | 0 | 0 | €33.10 | - | - |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.06 | €20.00 | 4.932% |
| Gerresheimer AG | 4 | 0 | 0 | 0 | €104.20 | - | - |
| Hologic Inc. | 19 | 0 | 0 | 0 | €74.50 | €83.38 | 11.914% |
| Steris Corp. | 1 | 0 | 0 | 0 | €220.00 | - | - |
| Sartorius AG VZO | 3 | 0 | 0 | 0 | €234.50 | - | - |
| TG Therapeutics Inc. | 20 | 1 | 0 | 0 | €20.47 | €31.12 | 52.045% |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 0 | 0 | €197.00 | €239.41 | 21.527% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €424.70 | €554.23 | 30.499% |
| Eli Lilly Corp. | 70 | 0 | 2 | 0 | €866.30 | €883.50 | 1.985% |
| Sanofi S.A. ADR | 8 | 0 | 1 | 0 | €52.50 | €55.25 | 5.246% |
| Esperion Therapeutis.Inc. | 17 | 1 | 1 | 0 | €1.65 | €9.27 | 460.968% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €74.50 | €75.37 | 1.168% |